As one of the most important non-communicable diseases of our time, diabetes affects both young and old, irrespective of gender or ethnicity. Beta-Cell’s cell replacement therapy brings a cure within reach for the first time. The mission of Beta-Cell is to provide a cure for type 1 insulin-dependent diabetes patients.
Diabetes is a chronic disorder characterized by elevated blood glucose levels. It arises when the natural interplay between the hormones insulin and glucagon fails. Current treatments manage and control blood glucose levels but do not cure the disease, putting a tremendous financial and mental burden on patients, families and society as a whole.
There is a significant unmet medical need for a safe, readily available and sustainable, physiologically regulated insulin source. BetaGraft cell factories mimic the biological action of the pancreas to restore cellular control of blood sugar levels with sustained adaptation to the needs of the body
Beta-Cell’s progress towards a cure for diabetes is driven by recognized scientific experts and an experienced leadership team. An actively engaged supervisory board supports this endeavor. Together we strive to create solutions that will have a profound impact on the everyday life of millions of patients.